Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICH-2: Remote Ischemic Conditioning for ICH
NCT04657133Phase 3Unknown
- Sponsor
- Capital Medical University
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Capital Medical University. Primary endpoint: Proportion of Patients With Modified Rankin Scale Score 0-2 at 90 days. Status: unknown.
Beyond the preview
Go deeper on NCT04657133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657133.